FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of A 002 when added to
high dose atorvastatin in subjects with an acute coronary syndrome (ACS)